GH Stock Analysis: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$118.95
0.94 (0.80%)
β²
5d:
+25.32%
30d:
+35.37%
90d:
+25.98%
WAIT
LOW Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called GH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: GH is 15.8% above its trading range ($102.70). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: GH is 15.8% above its trading range ($102.70). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $118.95, which is considered extended relative to its 30-day fair value range of $84.12 to $102.70.
Technical Outlook: Technically, GH is in a downtrend. The price is approaching resistance at $121.01. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GH is in a downtrend. The price is approaching resistance at $121.01. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$84.12 -
$102.70
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
Protect Your Profits
GH is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+15.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($130.52)
- WARNING: Recommendation downgraded due to 15.8% overvaluation
Trading Range Analysis
30-Day Trading Range
$84.12 -
$102.70
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$89.07
Resistance Level
$121.01
Current Trend
Downtrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-192.79
Wall Street Target
$130.52
(+9.7%)
Revenue Growth (YoY)
48.3%
Profit Margin
-40.1%
Share & Embed Analysis
Last updated: May 24, 2026 8:30 PM ET
Data refreshes hourly during market hours. Next update: 9:30 PM
Data refreshes hourly during market hours. Next update: 9:30 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
Musa Tariq
SELL
116 shares
2026-04-16
Terilyn J Monroe
SELL
3832 shares
2026-04-06
Musa Tariq
SELL
348 shares
2026-03-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific⦠|
STRONG BUY
31 analysts |
$612 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati⦠|
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 63 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 62 BUY |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$229 | 57 HOLD |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.